Genomic Testing Guidelines in Oncology | Shayma Kazmi, MD, RPh | Open Mic May
Dr. Arturo Loaiza-Bonilla, Gastrointestinal Program Director and Medical Director of Clinical Research at Cancer Treatment Centers of America, explains how AI can be used to optimize patient care, particularly how potential applications are being developed for AI in oncology.
It has been widely recognized that COVID-19 has led to “democratization” of clinical trial conduct with increase incorporation of telemedicine and virtual visits, allowance of local and less frequent testing including imaging, lower administrative burden, allowing drugs to be self-administered by patients and less stringent follow-up restrictions. This may lead to a technological revolution in the conduct of clinical trials with an emphasis on patient preference and safety while preserving scientific integrity. Novel technologies around decentralized clinical trials, ‘Just-In-Time (JIT) activation, use of apps and wearables, and a NASA-style Clinical Trial Mission Control Center could leverage AI solutions, which may lead to new FDA policies and regulations for R&D post COVID-19.
COVID-19 and Its Impact on Oncology Clinical Trials: https://bit.ly/2QAya1Q
Massive Bio Launches Industry’s First NASA-Style, Oncology Clinical Trial Command Center: https://bwnews.pr/3td7AJr
Open Mic May is content series that opens the floor for oncology experts to share the research and initiatives they're passionate about. New videos go live every Monday, Wednesday, and Friday at 3:00 pm EST throughout the month of May 2021. Subscribe to our channel for updates and follow us on Twitter at @totalhealthconf.